BERNOCCO, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 566
EU - Europa 392
AS - Asia 185
AF - Africa 13
OC - Oceania 2
SA - Sud America 1
Totale 1.159
Nazione #
US - Stati Uniti d'America 562
CN - Cina 109
DE - Germania 108
AT - Austria 69
SG - Singapore 58
SE - Svezia 54
IE - Irlanda 34
IT - Italia 33
FR - Francia 29
FI - Finlandia 20
UA - Ucraina 19
SN - Senegal 13
KR - Corea 10
GB - Regno Unito 5
GR - Grecia 5
PL - Polonia 5
RU - Federazione Russa 5
CA - Canada 4
BE - Belgio 3
AU - Australia 2
IN - India 2
SA - Arabia Saudita 2
CO - Colombia 1
IL - Israele 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 1.159
Città #
Chandler 116
Beijing 75
Vienna 69
Singapore 50
Ashburn 35
Dublin 34
Santa Clara 34
Ann Arbor 30
Nyköping 25
Dearborn 22
Villeurbanne 22
Houston 19
Jacksonville 18
Medford 18
Princeton 14
Fremont 13
San Mateo 13
Munich 12
Torino 10
Columbus 9
Woodbridge 8
Florence 6
Nürnberg 6
Guangzhou 5
Warsaw 5
Washington 5
Wilmington 5
Boardman 4
Brussels 3
Düsseldorf 3
Nanjing 3
New York 3
Norwalk 3
Philadelphia 3
Chicago 2
Des Moines 2
Edinburgh 2
Hefei 2
Kunming 2
Leawood 2
Milan 2
Moscow 2
Ottawa 2
Redwood City 2
Stockholm 2
Taranto 2
Toronto 2
Chengdu 1
Chennai 1
Chisinau 1
Dallas 1
Falls Church 1
Formigine 1
Fort Belvoir 1
Handan 1
Hebei 1
Jinan 1
Jinhua 1
Köln 1
Los Angeles 1
Luxembourg 1
Medellín 1
Mezzolombardo 1
Nardò 1
Ningbo 1
Noto 1
Odesa 1
Ramat Gan 1
Shanghai 1
Shaoxing 1
Sioux Falls 1
Trofarello 1
Verona 1
Vigliano Biellese 1
Xining 1
Zhengzhou 1
Totale 755
Nome #
Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL) 150
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES 128
Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia 109
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom 108
PROGRESSIVE TELOMERE SHORTENING DURING THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA 102
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) 97
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 96
Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome 95
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up 86
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia 82
null 64
Khorana score and histotype predicts incidence of early venous thromboembolism in Non-Hodgkin lymphomas: A Pooled-Data analysis of 12 clinical trials of fondazione italiana linfomi (FIL) 53
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. 26
Totale 1.196
Categoria #
all - tutte 3.500
article - articoli 0
book - libri 0
conference - conferenze 2.077
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202095 0 0 0 0 8 25 23 4 10 8 9 8
2020/202187 14 7 0 2 10 2 4 1 7 11 24 5
2021/2022143 2 1 1 8 4 2 28 9 3 13 44 28
2022/2023270 29 32 2 41 18 63 10 22 22 16 9 6
2023/202490 10 22 8 3 2 14 0 17 0 2 2 10
2024/2025146 1 25 13 38 69 0 0 0 0 0 0 0
Totale 1.196